Neutrophils Enable Local and Non-Invasive Liposome Delivery to Inflamed Skeletal Muscle and Ischemic Heart

Area of Science:

• Biomedical Engineering
• Immunology
• Nanotechnology

Background:

• Uncontrolled inflammation is a key factor in diseases like autoimmune conditions, cardiovascular disease, and cancer.
• Systemic administration of immunosuppressive drugs causes severe side effects due to lack of targeted delivery.
• Localized drug delivery to inflamed tissues offers a promising therapeutic strategy.

Purpose of the Study:

• To develop a neutrophil-mediated drug delivery system for targeted delivery of nanocarriers to inflamed tissues.
• To evaluate the efficacy of this system in reducing inflammation and promoting tissue regeneration.
• To establish a universal platform for delivering anti-inflammatory drugs.

Main Methods:

• Ex vivo loading of liposomes (drug-loaded nanocarriers) into neutrophils.
• In vitro assessment of neutrophil migration towards inflammatory chemokine gradients.
• In vivo studies in mice to confirm drug delivery to inflamed skeletal muscle and myocardial tissue.
• Evaluation of local inflammatory cytokine levels post-injection.

Main Results:

• Neutrophil-liposome hybrid systems efficiently migrated towards inflammatory signals in vitro.
• In vivo studies demonstrated successful delivery of liposomes to inflamed tissues in mice.
• A single low-dose injection of the hybrid system significantly reduced local inflammatory cytokine levels.
• Biodistribution studies confirmed neutrophil-mediated delivery to inflammation sites in a myocardial ischemia reperfusion injury model.

Conclusions:

• Neutrophil-loaded liposomes represent an effective system for targeted delivery of anti-inflammatory drugs.
• This strategy holds potential as a universal platform for treating inflammatory diseases and promoting tissue regeneration.
• Non-invasive, localized drug delivery via neutrophils can mitigate side effects associated with systemic administration.